Cereblon in health and disease

被引:36
作者
Kim, Hyoung Kyu [1 ,2 ]
Ko, Tae Hee [1 ]
Nyamaa, Bayalagmaa [1 ]
Lee, Sung Ryul [1 ,2 ]
Kim, Nari [1 ]
Ko, Kyung Soo [1 ]
Rhee, Byoung Doo [1 ]
Park, Chul-Seung [3 ,4 ]
Nilius, Bernd [5 ]
Han, Jin [1 ]
机构
[1] Inje Univ, Natl Res Lab Mitochondrial Signaling, Cardiovasc & Metab Dis Ctr, Dept Physiol,Dept Hlth Sci & Technol,Coll Med,Plu, Bokji Ro 75, Busan 47392, South Korea
[2] Inje Univ, Dept Integrated Biomed Sci, Coll Med, Busan, South Korea
[3] Gwangju Inst Sci & Technol, Sch Life Sci, Gwangju 500712, South Korea
[4] Gwangju Inst Sci & Technol, Natl Leading Res Lab Ion Channels, Gwangju 500712, South Korea
[5] Katholieke Univ Leuven, Lab Ion Channel Res, Dept Cellular & Mol Med, Leuven, Belgium
来源
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY | 2016年 / 468卷 / 08期
基金
新加坡国家研究基金会;
关键词
Cereblon; Mental retardation; BKCa; E3 ligase complex; AMPK; Immunomodulatory drugs; CHRONIC LYMPHOCYTIC-LEUKEMIA; E3 UBIQUITIN LIGASE; IDIOPATHIC GENERALIZED EPILEPSY; ENDOPLASMIC-RETICULUM STRESS; MULTIPLE-MYELOMA CELLS; BK CHANNEL ACTIVITY; MENTAL-RETARDATION; THALIDOMIDE TERATOGENICITY; CONFORMATIONAL DEFECT; POTASSIUM CHANNEL;
D O I
10.1007/s00424-016-1854-1
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Cereblon (CRBN) is a substrate receptor of the E3 ubiquitin ligase complex that has been linked to autosomal recessive non-syndromic mental retardation. Several key findings suggest diverse roles of CRBN, including its regulation of the large-conductance calcium- and voltage-activated potassium (BKCa) channels, regulation of thalidomide-binding proteins, and mediation of lenalidomide treatment in multiple myeloma. Recent studies also indicate that CRBN is involved in energy metabolism and negatively regulates AMP-activated protein kinase signaling. Mice with genetic depletion of CRBN are resistant to various stress conditions including a high-fat diet, endoplasmic reticulum stress, ischemia/reperfusion injury, and alcohol-related liver damage. In this review, we discuss the various roles of CRBN in human health and disease and suggest avenues for further research to enhance our basic knowledge and clinical application of CRBN.
引用
收藏
页码:1299 / 1309
页数:11
相关论文
共 83 条
  • [1] [Anonymous], 2016, PFLUGERS ARCH EUR J, V468, P1299
  • [2] Ubiquitination-dependent quality control of hERG K+ channel with acquired and inherited conformational defect at the plasma membrane
    Apaja, Pirjo M.
    Foo, Brian
    Okiyoneda, Tsukasa
    Valinsky, William C.
    Barriere, Herve
    Atanasiu, Roxana
    Ficker, Eckhard
    Lukacs, Gergely L.
    Shrier, Alvin
    [J]. MOLECULAR BIOLOGY OF THE CELL, 2013, 24 (24) : 3787 - 3804
  • [3] Thalidomide and lenalidomide as new therapeutics for the treatment of chronic lymphocytic leukemia
    Awan, Farrukh T.
    Johnson, Amy J.
    Lapalombella, Rosa
    Hu, Weihong
    Lucas, Margaret
    Fischer, Beth
    Byrd, John C.
    [J]. LEUKEMIA & LYMPHOMA, 2010, 51 (01) : 27 - 38
  • [4] AMPK activation, a preventive therapeutic target in the transition from cardiac injury to heart failure
    Beauloye, Christophe
    Bertrand, Luc
    Horman, Sandrine
    Hue, Louis
    [J]. CARDIOVASCULAR RESEARCH, 2011, 90 (02) : 224 - 233
  • [5] Rate of CRL4CRBN substrate Ikaros and Aiolos degradation underlies differential activity of lenalidomide and pomalidomide in multiple myeloma cells by regulation of c-Myc and IRF4
    Bjorklund, C. C.
    Lu, L.
    Kang, J.
    Hagner, P. R.
    Havens, C. G.
    Amatangelo, M.
    Wang, M.
    Ren, Y.
    Couto, S.
    Breider, M.
    Ning, Y.
    Gandhi, A. K.
    Daniel, T. O.
    Chopra, R.
    Klippel, A.
    Thakurta, A. G.
    [J]. BLOOD CANCER JOURNAL, 2015, 5 : e354 - e354
  • [6] Leukoencephalopathy upon disruption of the chloride channel ClC-2
    Blanz, Judith
    Schweizer, Michaela
    Auberson, Muriel
    Maier, Hannes
    Muenscher, Adrian
    Huebner, Christian A.
    Jentsch, Thomas J.
    [J]. JOURNAL OF NEUROSCIENCE, 2007, 27 (24) : 6581 - 6589
  • [7] High cereblon expression is associated with better survival in patients with newly diagnosed multiple myeloma treated with thalidomide maintenance
    Broyl, Annemiek
    Kuiper, Rowan
    van Duin, Mark
    van der Holt, Bronno
    el Jarari, Laila
    Bertsch, Uta
    Zweegman, Sonja
    Buijs, Arjan
    Hose, Dirk
    Lokhorst, Henk M.
    Goldschmidt, Hartmut
    Sonneveld, Pieter
    [J]. BLOOD, 2013, 121 (04) : 624 - 627
  • [8] Control of vertebrate limb outgrowth by the proximal factor Meis2 and distal antagonism of BMPs by Gremlin
    Capdevila, J
    Tsukui, T
    Esteban, CR
    Zappavigna, V
    Belmonte, JCI
    [J]. MOLECULAR CELL, 1999, 4 (05) : 839 - 849
  • [9] CARTER CJ, 1981, LANCET, V1, P1427
  • [10] A third-generation IMiD for MM
    Cavo, Michele
    [J]. BLOOD, 2011, 118 (11) : 2931 - 2932